Patents by Inventor William M. Snyder

William M. Snyder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240175161
    Abstract: The application is directed towards systems and methods for aluminum purification. A system, comprising: a cell defining a chamber having upper portion and lower portion; the lower portion including a cathode molten material collection area; an anode structure disposed in the upper portion vertically aligned above the lower portion; a cathode structure disposed in the upper portion vertically aligned above the cathode molten material collection area; and a liquid electrolyte within the chamber in fluid communication with the anode structure and the cathode structure, the liquid electrolyte having electrolyte density; the anode structure is configured to receive impure aluminum having impure aluminum density greater than the electrolyte density, and the cathode structure captures purified aluminum having purified aluminum density greater than the electrolyte density, the cathode structure defining a cathode flow path along which purified aluminum can flow.
    Type: Application
    Filed: February 2, 2024
    Publication date: May 30, 2024
    Applicant: REYNOLDS CONSUMER PRODUCTS LLC
    Inventors: Boyd R. Davis, Timothy M. Snyder, William Courchesne
  • Patent number: 6436961
    Abstract: The present invention relates to a novel process for preparing and resolving 3-amino-2-phenylpiperidine and for synthesizing from the enantiomers of such compound certain pharmaceutically active substituted 2-phenyl-3-benzylaminopiperidines. The substituted 2-phenyl-3-benzylaminopiperidines that can be prepared by the processes of this invention are substance P receptor antagonists and are useful in the treatment and prevention of inflammatory and central nervous system disorders, as well as several other disorders.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: August 20, 2002
    Assignee: Pfizer INC
    Inventors: Harry A. Watson, Jr., William M. Snyder, Glenn E. Wilcox
  • Patent number: 4997981
    Abstract: An amine substituion process for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole, for precursor N-(pentylamidino)thiourea, and for analogs thereof of said compounds.
    Type: Grant
    Filed: April 20, 1989
    Date of Patent: March 5, 1991
    Assignee: Pfizer Inc.
    Inventors: Paul D. Hill, William M. Snyder, Stanley W. Walinsky